Literature DB >> 20714774

Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.

Mohamed Ismail Abd-Elkareem1, Hegazy Mogahed Al Tamimy, Osama A Khamis, Salama S Abdellatif, Mahmoud Rezk Abdelwahed Hussein.   

Abstract

BACKGROUND: Leukocyte adhesion molecules are important for migration of the inflammatory cells into sites of inflammation. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are members of the immunoglobulin superfamily that are expressed in normal kidney. Their expression is up-regulated in the renal tissue of patients with lupus nephritis (LN).
OBJECTIVES: We evaluated whether changes in urinary levels of ICAM-1 and VCAM-1 reflect renal tissue damage in LN. We related the levels of these molecules to other laboratory findings, especially complement C3/C4 levels. We also tested the hypothesis that changes in urinary levels of ICAM-1 and VCAM-1 reflect the severity of renal tissue damage in LN. PATIENTS AND METHODS: This study included 30 systemic lupus erythematosus (SLE) patients with LN (16 with mild histological changes, i.e., with World Health Organization (WHO) class I and II LN, and 14 with advanced histological changes, i.e., class III, IV, and V LN) and 20 with SLE without nephritis. In addition, 20 healthy individuals of comparable age were included as a control group. The levels of urinary ICAM-1 and VCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA) and related to the clinical, laboratory [rheumatoid factor(RF), antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), complements C3 and C4] and histological findings.
RESULTS: Levels of urinary ICAM-1 and VCAM-l in LN patients with advanced histological changes (renal damage) were statistically significantly higher than those in other groups (LN patients with mild histological changes or SLE patients without nephritis and control group; p < 0.01). In contrast, serum levels of C3 and C4 in LN patients with advanced histological changes were significantly lower than those in other groups (p < 0.01). There was a significant negative correlation between the levels of urinary adhesion molecules and serum complement levels (p < 0.01).
CONCLUSIONS: The significantly high urinary levels of the adhesion molecules in the LN group with advanced histological changes may reflect their renal tissue expression and therefore the severity of the nephritis. Renal tissue damage in these cases may be the result of transmigration of activated inflammatory cells, inducing serious tissue damage. The hypocomplementemia combined with increased urinary levels of adhesion molecules seems to be a useful biomarker of disease severity in LN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714774     DOI: 10.1007/s10157-010-0322-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  40 in total

Review 1.  [Adhesion molecules and glomerulonephritis. Towards novel therapeutic strategies].

Authors:  Pilar Arrizabalaga Clemente
Journal:  Med Clin (Barc)       Date:  2002-06-29       Impact factor: 1.725

2.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

3.  Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis.

Authors:  K Lhotta; H P Neumayer; M Joannidis; D Geissler; P König
Journal:  Clin Sci (Lond)       Date:  1991-10       Impact factor: 6.124

4.  Renal biopsy in lupus patients with low levels of proteinuria.

Authors:  Lisa Christopher-Stine; Mark Siedner; Janice Lin; Mark Haas; Hemal Parekh; Michelle Petri; Derek M Fine
Journal:  J Rheumatol       Date:  2006-12-15       Impact factor: 4.666

5.  Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo: correlation with immigration of monocytes.

Authors:  U Henseleit; K Steinbrink; C Sunderkötter; M Goebeler; J Roth; C Sorg
Journal:  Exp Dermatol       Date:  1995-10       Impact factor: 3.960

6.  [Expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in kidney of patients with lupus nephritis and membranoproliferative glomerulonephritis].

Authors:  X Chen; Q Xu; L Tang
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1995-06

7.  Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum.

Authors:  T B Ledue; D L Weiner; J D Sipe; S E Poulin; M F Collins; N Rifai
Journal:  Ann Clin Biochem       Date:  1998-11       Impact factor: 2.057

8.  Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders.

Authors:  P L Tan; G B Borman; R D Wigley
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

9.  Effects of shikonin isolated from zicao on lupus nephritis in NZB/W F1 mice.

Authors:  Xin Chang Wang; Jian Feng; Feng Huang; Yong Sheng Fan; Yan Yan Wang; Ling Yong Cao; Cheng Pin Wen
Journal:  Biol Pharm Bull       Date:  2009-09       Impact factor: 2.233

10.  Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis.

Authors:  R P Wuthrich; A M Jevnikar; F Takei; L H Glimcher; V E Kelley
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more
  23 in total

1.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

Review 2.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

3.  Systemic lupus erythematosus diagnostics in the 'omics' era.

Authors:  Cristina Arriens; Chandra Mohan
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

Review 4.  Proteomic profiling of urine: implications for lupus nephritis.

Authors:  Najla Aljaberi; Michael Bennett; Hermine I Brunner; Prasad Devarajan
Journal:  Expert Rev Proteomics       Date:  2019-03-18       Impact factor: 3.940

5.  CSTMP Exerts Anti-Inflammatory Effects on LPS-Induced Human Renal Proximal Tubular Epithelial Cells by Inhibiting TLR4-Mediated NF-κB Pathways.

Authors:  Yan Ding; Wang Liao; Xiaojie He; Wei Xiang; Qianjin Lu
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

Review 6.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

7.  Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.

Authors:  Tianfu Wu; Yong Du; Jie Han; Sandeep Singh; Chun Xie; Yuyuan Guo; Xin J Zhou; Chul Ahn; Ramesh Saxena; Chandra Mohan
Journal:  Mol Cell Proteomics       Date:  2013-01-23       Impact factor: 5.911

8.  Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Authors:  Yumin Xia; Sean R Campbell; Anna Broder; Leal Herlitz; Maria Abadi; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-08-20       Impact factor: 3.969

9.  Low level of circulating basophil counts in biopsy-proven active lupus nephritis.

Authors:  Peifen Liang; Ying Tang; Liu Lin; Haowen Zhong; Hui Yang; Yuchun Zeng; Jun Lv; Xiaomei Li; Yanying Lu; Anping Xu
Journal:  Clin Rheumatol       Date:  2017-10-08       Impact factor: 2.980

Review 10.  Urine biomarkers in juvenile-onset SLE nephritis.

Authors:  Louise Watson; Michael W Beresford
Journal:  Pediatr Nephrol       Date:  2012-05-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.